-
Antiviral API
- Arenavirus
- Cytomegalovirus (CMV)
- Dengue virus
- Endogenous Metabolite
- Enterovirus (EV)
- Epstein-Barr virus (EBV)
- Filovirus
- Flavivirus
- HCV Protease
- Hepatitis B Virus (HBV)
- Hepatitis C Virus (HCV)
- Herpes simplex Virus (HSV)
- HIF/HIF Prolyl-Hydroxylase
- HIV Integrase
- HIV Protease
- Human immunodeficiency Virus (HIV)
- Human papillomavirus (HPV)
- Influenza Virus
- Nipah virus
- Orthopoxvirus
- Others
- Rabies virus (RABV)
- Respiratory syncytial Virus (RSV)
- Reverse Transcriptases (RTs)
- SARS-CoV
- Tobacco mosaic virus (TMV)
- Vesicular stomatitis virus (VSV)
- Virus Protease
- West Nile virus
- Antiviral intermediates
2'-C-Methylcytidine
Category | Hepatitis C Virus (HCV) |
CAS | 20724-73-6 |
Description | A nucleoside analog with anti-hepatitis C virus (HCV) activity. Upon phosphorylation into its 5-triphosphate form, this metabolite inhibits viral RNA chain elongation and viral RNA-dependent RNA polymerase activity. This blocks viral production of HCV RNA and thus viral replication. |
Product Information
Synonyms | 1-((2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-3-methyltetrahydrofuran-2-yl)-4-aminopyrimidin-2(1H)-one; 2'-C-methyl-cytidine; valopicitabine; Cytidine, 2'-C-methyl-; (+)-2'-C-Methylcytidine; NM 107 |
IUPAC Name | 4-amino-1-[(2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-3-methyloxolan-2-yl]pyrimidin-2-one |
Molecular Weight | 257.24 |
Molecular Formula | C10H15N3O5 |
Canonical SMILES | CC1(C(C(OC1N2C=CC(=NC2=O)N)CO)O)O |
InChI | InChI=1S/C10H15N3O5/c1-10(17)7(15)5(4-14)18-8(10)13-3-2-6(11)12-9(13)16/h2-3,5,7-8,14-15,17H,4H2,1H3,(H2,11,12,16)/t5-,7-,8-,10-/m1/s1 |
InChIKey | PPUDLEUZKVJXSZ-VPCXQMTMSA-N |
Boiling Point | 523.9±60.0 °C at 760 mmHg |
Melting Point | 243-245 °C |
Flash Point | 270.7±32.9 °C |
Purity | ≥95% |
Density | 1.72±0.10 g/cm3 |
Solubility | Soluble in DMSO |
Appearance | white to off-white powder |
Shelf Life | 2 years |
Storage | Store in a cool and dry place and at 2-8 °C for short term (days to weeks) or -20 °C for long term (months to years) |
Complexity | 424 |
Exact Mass | 257.10117059 |
Index Of Refraction | 1.700 |
In Vitro | NM107 is a potent and selective inhibitor of flavi- and pesti-virus replication in cell culture, with inhibitory activity and cytotoxicity against HCV 1b replicon cells, IC50 is 1.13 μM. Intracellular HCV RNA in HCV-infected cells treated the HCV polymerase inhibitor NM107 shows a similar pattern of decline. NM107 are currently being investigated as additional therapeutic agents for HCV infection. NM107 inhibits bovine viral diarrhea virus (BVDV) replication (EC50 0.67 nM), eliminates persistent BVDV infection at nontoxic concentrations. |
PSA | 130.83000 |
Target | HCV |
Vapor Pressure | 0.0±3.1 mmHg at 25°C |
XLogP3-AA | -2.4 |